Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-18-000024
Filing Date
2018-05-08
Accepted
2018-05-08 16:31:30
Documents
60
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20180331x10q.htm 10-Q 1011064
2 EX-31.1 plse-20180331xex31_1.htm EX-31.1 20422
3 EX-31.2 plse-20180331xex31_2.htm EX-31.2 20867
4 EX-32.1 plse-20180331xex32_1.htm EX-32.1 19352
  Complete submission text file 0001625101-18-000024.txt   4165056

Data Files

Seq Description Document Type Size
5 EX-101.INS plse-20180331.xml EX-101.INS 824732
6 EX-101.SCH plse-20180331.xsd EX-101.SCH 31972
7 EX-101.CAL plse-20180331_cal.xml EX-101.CAL 44153
8 EX-101.DEF plse-20180331_def.xml EX-101.DEF 109916
9 EX-101.LAB plse-20180331_lab.xml EX-101.LAB 271759
10 EX-101.PRE plse-20180331_pre.xml EX-101.PRE 230895
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 18815112
SIC: 3841 Surgical & Medical Instruments & Apparatus